Boulder’s life sciences cluster grows as CordenPharma Colorado expands peptide R&D footprint
CordenPharma Colorado expands peptide development capacity with a new Boulder lab facility. Discover what this means for peptide drug manufacturing.
Pharma & Biotech
Pharma & Biotech
Eli Lilly’s $6bn API plant in Alabama signals new era in U.S. peptide drug manufacturing
Eli Lilly’s $6B Alabama facility will manufacture orforglipron and peptide APIs. Explore how this reshoring move could transform U.S. drug manufacturing.